Immuno-gene therapies represent a transformative frontier, combining genetic engineering with the body’s...
Recognising the regulatory shift brought about by the Insurance Regulatory and Development Authority, IRD...
Aditya Oza, co-founder of EMotorad, and Mikhail Bohra, co-founder of Harbor 365, have announced the launch of ...
Advancing Affordable Indigenous IMMUNOTHERAPIES
Immunotherapy is transforming modern medicine by offering targeted, effective, and less toxic treatments for cancer, autoimmune disorders, and infectious diseases. As global demand for these therapies grows, India is rapidly positioning itself as a key player in their development and large-scale production. We shall take a deep dive into India’s immunotherapy research pipeline—what’s driving it, what’s holding it back, and whether the country can truly emerge as a global hub for affordable immunotherapy.
For Feedback, please email us at: communications@mmactiv.com
Sign up here to access BioSpectrum India Flip Book.
Sign up here to access BioSpectrum India Flip Book